To the best of our knowledge, this is the first study investigating the multimorbidity and polytherapy profile of a large population of patients receiving intravitreal injections of anti-VEGF drugs and dexamethasone for retinal diseases. The gene discussed is VEGFA; the disease is Abnormal retinal morphology.